BBAL — New York Health Care Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$5.20m
- $44.40m
Annual income statement for New York Health Care, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2003 December 31st | R2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 38.6 | 42.3 | 44.7 | 45.6 | 44.4 |
| Cost of Revenue | |||||
| Gross Profit | 6.71 | 7.5 | 7.64 | 8.81 | 7.77 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 60.7 | 48.5 | 53.8 | 49.3 | 45.6 |
| Operating Profit | -22.1 | -6.23 | -9.09 | -3.79 | -1.22 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -22.1 | -6.19 | -9.03 | -3.68 | -0.978 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -22.1 | -6.12 | -9.1 | -3.76 | -1.05 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -22.1 | -6.07 | -6.32 | -3.76 | -1.05 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -22.1 | -6.07 | -6.32 | -3.76 | -1.05 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.433 | -0.2 | -0.285 | -0.095 | -0.016 |
| Dividends per Share |